FDA Withdraws Proposed Rule for Infant Apnea Monitor Performance Standard

Summary

The FDA is withdrawing its proposed rule for a mandatory performance standard for infant apnea monitors, citing declining birth rates and reduced infant mortality, and instead will provide industry guidance on minimum performance and testing requirements.